The Latest Breaking News from MCK

The healthcare industry is expanding, fueled by the increasing demand and advancements such as personalized medicines and telehealth. Hence, fundamentally strong healthcare stocks Abbott Laboratories (ABT), Centene (CNC), and McKesson (MCK) might be worth buying in 2023. Read more.

Renowned investor Warren Buffett’s value investing strategy has guided investors for decades. Buffett’s Berkshire Hathaway has significantly outperformed the broader market over the past six months. During periods of economic uncertainty, fundamentally sound Warren Buffett stocks Johnson & Johnson (JNJ) and McKesson Corp. (MCK) seem like no-brainer investments for solid…

With expanding medical needs and technological advancements, the healthcare industry’s prospects look impressive. Moreover, healthcare stocks tend to perform relatively well, irrespective of economic conditions, thanks to the inelastic demand for their products and services. Therefore, we think Nature’s Sunshine Products (NATR), Abbott Laboratories (ABT), Humana (HUM), Molina Healthcare (MOH),…

The medical industry is poised for growth this year, driven by expanding medical needs and increasing federal support. Moreover, the industry is expected to thrive in times of uncertainty due to steady demand. Thus, quality medical stocks McKesson Corp. (MCK) and Cardinal Health (CAH) could be ideal buys this year.…

Popular healthcare service provider McKesson (MCK) has delivered robust returns despite the market turbulence over the past year. Moreover, MCK’s solid fundamentals should help it to sustain its momentum. Thus, the stock might be an ideal buy for 2023. Keep reading.

Despite mass layoffs, the U.S. economy looks resilient enough to avoid a recession. Moreover, consumer sentiment remains pretty robust. Therefore, investors could consider buying quality stocks CVS Health (CVS), McKesson (MCK), and Archer-Daniels-Midland (ADM), which look poised to soar this year. Keep reading.

The Fed’s constant rate hikes have caused significant market volatility and increased recession fears. However, the Fed might slow the pace of hikes in the near term. While uncertainties remain, we think investors could consider buying fundamentally solid stocks McKesson (MCK), Molina Healthcare (MOH), Progress Software (PRGS), and Universal Logistics…

With the Fed’s continued interest-rate hikes expected to keep markets in perpetual turmoil, it would be opportune to load up on McKesson (MCK). The recession-resistant medical services market leader’s enduring competitive advantages and attractive valuation have also earned it a place in the portfolio of Warren Buffett-led Berkshire Hathaway (BRK).…

While the moderate inflation rate for November has boosted investor sentiment and may have paved the way for lower interest rate hikes from this month, Fed’s recent comments suggest that the target interest rate may be a bit further ahead. Hence shares of fundamentally strong businesses with robust demand, such…